Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Gastrointestinal Drugs Market Briefing 2017 - Vitamin And Minerals, Antacids, Antiemetics And Antinauseants, Antiobesity, Antidiarrhoeals - Research and Markets

Research and Markets
Posted on: 03 Jan 18

The "Gastrointestinal Drugs Market Global Briefing 2017" report has been added to Research and Markets' offering.

The global gastrointestinal drugs market is expected to reach around $60 billion in 2020. This can be attributed to the expected increase in prevalence of obesity and digestive diseases globally.

The gastrointestinal diseases drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors, Sucralfate, and Misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants, hyperosmotic, saline, and simulant/irritant.

Tranexamic Acid To Treat Gastrointestinal Bleeding - Drug manufacturing companies are offering tranexamic acid for the treatment of acute gastrointestinal bleeding. Tranexamic acid is a medication used to treat or prevent excessive blood loss from major trauma or surgery and is now finding applications for gastrointestinal diseases. Tranexamic acid reduces clot breakdown, thus reducing the duration and amount of bleeding. This reduces mortality rate (from 10% to 7.5%) and the probability of blood transfusion by about 30%. Major companies manufacturing tranexamic acid include Abbott Laboratories, Pfizer, GlaxoSmithKline and Bayer AG.

Scope:

  • Markets Covered: Antiulcerants, Vitamin And Minerals, Antacids, Antiemetics And Antinauseants, Antiobesity, Antidiarrhoeals
  • Time Series: Five years historic and forecast.
  • Data: Market value in $ billions.
  • Data Segmentations: Regional breakdowns, market share of competitors, key sub segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

  • Takeda Pharmaceuticals
  • Allergan Plc.
  • Novo Nordisk A/S
  • AstraZeneca Plc.
  • Johnson & Johnson
  • Bayer AG
  • Otsuka Pharmaceutical Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/sx6ztz/global?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180103005995/en/

Business Wire
www.businesswire.com

Last updated on: 03/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.